Literature DB >> 8816288

Overexpression of microfilament-stabilizing human caldesmon fragment, CaD39, affects cell attachment, spreading, and cytokinesis.

K S Warren1, D C Shutt, J P McDermott, J L Lin, D R Soll, J J Lin.   

Abstract

Previous studies have demonstrated that overexpression of the carboxyl-terminal fragment, CaD39, of human fibroblast caldesmon in Chinese hamster ovary cells protected endogenous tropomyosin from turnover and stabilized actin microfilament bundles [Warren et al., 1994: J. Cell Biol. 125:359-368]. To assess the consequences of having CaD39-stabilized microfilaments in living cell, we characterized the motile behaviors of stable CaD39-expressing lines. We here found that CaD39-expressing cells adhered faster to plastic, glass, fibronectin-coated glass, and collagen-coated glass than control cells. Moreover, the CaD39-expressing cells also exhibited enhanced spreading immediately after attachment. Despite these differences, overexpression of CaD39 had little effect on the velocity of intracellular granule movement, or the velocity and persistence of cellular translocation. However, CaD39-expressing cells were more elongate and encompassed less area than non-expressing cells during migration in a wound-healing assay. In interphase cells, the expressed CaD39 fragments were found associated with tropomyosin-enriched microfilaments. Like endogenous caldesmon, the CaD39 fragment was also modified at mitosis. Although a significant portion of CaD39 underwent only partial modification, the majority of the CaD39 was released from the microfilaments during mitosis. This is consistent with the finding that the CaD39-induced advantage for attachment and spreading was lost during mitosis. In CaD39-expressing cells, an incomplete release of the CaD39 from microfilaments at mitosis was found which may be responsible for the increase in the frequency of multinuclear cells in CaD39-expressing lines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816288     DOI: 10.1002/(SICI)1097-0169(1996)34:3<215::AID-CM5>3.0.CO;2-8

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  8 in total

Review 1.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

2.  Calcium-dependent regulation of interactions of caldesmon with calcium-binding proteins found in growth cones of chick forebrain neurons.

Authors:  A R Alexanian; J R Bamburg; H Hidaka; D Mornet
Journal:  Cell Mol Neurobiol       Date:  2001-10       Impact factor: 5.046

3.  Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability.

Authors:  Qifeng Jiang; Renjian Huang; Shaoxi Cai; Chih-Lueh A Wang
Journal:  J Biomed Sci       Date:  2010-02-03       Impact factor: 8.410

Review 4.  Caldesmon and the regulation of cytoskeletal functions.

Authors:  C L Albert Wang
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

5.  Caldesmon regulates actin dynamics to influence cranial neural crest migration in Xenopus.

Authors:  Shuyi Nie; Yun Kee; Marianne Bronner-Fraser
Journal:  Mol Biol Cell       Date:  2011-07-27       Impact factor: 4.138

6.  Quantitative analysis of hemocyte morphological abnormalities associated with Campoletis sonorensis parasitization.

Authors:  Matthew W Turnbull; Stacy B Martin; Bruce A Webb
Journal:  J Insect Sci       Date:  2004-04-15       Impact factor: 1.857

Review 7.  Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.

Authors:  Alya R Alnuaimi; Vidhya A Nair; Lara J Bou Malhab; Eman Abu-Gharbieh; Anu Vinod Ranade; Gianfranco Pintus; Mohamad Hamad; Hauke Busch; Jutta Kirfel; Rifat Hamoudi; Wael M Abdel-Rahman
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

8.  Caldesmon controls stress fiber force-balance through dynamic cross-linking of myosin II and actin-tropomyosin filaments.

Authors:  Shrikant B Kokate; Katarzyna Ciuba; Vivien D Tran; Reena Kumari; Sari Tojkander; Ulrike Engel; Konstantin Kogan; Sanjay Kumar; Pekka Lappalainen
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.